Ignite Creation Date:
2024-05-06 @ 1:00 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01705691
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2012-10-08
Brief Title:
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by AC in Women With Locally Advanced HER2-Negative Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
NSABP Foundation Inc
Organization Data
Organization:
NSABP Foundation Inc
Class:
NETWORK
Study ID:
NSABP FB-9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NSABP Foundation Inc
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eisai Inc | INDUSTRY |